Skip to main content
Kathy Helzlsouer, MD, Oncology, Baltimore, MD

KathyJHelzlsouerMD

Oncology Baltimore, MD

Physician

Dr. Helzlsouer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Helzlsouer's full profile

Already have an account?

  • Office

    227 Saint Paul Pl
    6TH floor
    Baltimore, MD 21202
    Phone+1 410-951-7950
    Fax+1 410-951-7931

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1985 - 1988
  • University of Virginia Medical Center
    University of Virginia Medical CenterResidency, Internal Medicine, 1979 - 1982
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 1979

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1982 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Next Steps in Studying the Human Microbiome and Health in Prospective Studies, Bethesda, MD, May 16–17, 2017  
    J Gregory Caporaso, Martin Blaser, Michael J Orlich, Mitchell H Gail, Heidi H Kong, Andrew T Chan, Kathy Helzlsouer, BioMed Central

Press Mentions

  • Breast Cancer in Blacks Spurs Hunt for Answers
    Breast Cancer in Blacks Spurs Hunt for AnswersFebruary 22nd, 2000
  • Breast Cancer in Blacks Spurs Hunt for Answers
    Breast Cancer in Blacks Spurs Hunt for AnswersFebruary 22nd, 2000
  • Short-Term Use of Immunosuppressants Not Linked to Cancer Risk
    Short-Term Use of Immunosuppressants Not Linked to Cancer RiskAugust 23rd, 2023

Grant Support

  • Reliability Of Ductal LavageNational Center For Research Resources2004
  • MacgnNational Center For Research Resources2004
  • CLUE Studies--Evaluating Biomarkers Of CarcinogenesisNational Cancer Institute2000–2004
  • Androgens, Growth Factors, And Ovarian CancerNational Cancer Institute2002–2003
  • Molecular Epidemiology Of Progression To Breast CancerNational Cancer Institute2000–2002
  • Gene-Environment Interactions: The Odyssey CohortNational Institute On Aging1999–2002
  • Institutional Research Cancer Epidemiology FellowshipNational Cancer Institute1999–2002
  • Clinical Trial To Determine Worth Of Tamoxifen For Breast Cancer PreventionNational Center For Research Resources1997–2002
  • Epidemiology Of Prostate Cancer--Odc And AR GenotypesNational Cancer Institute2000–2001
  • Environmental Factors And Breast Cancer Risk In MarylandNational Cancer Institute1993–1998
  • Molecular Epidemiology Of Prostate CancerNational Institute Of Environmental Health Sciences1995–1997
  • Antioxidant Nutrients And Lung Cancer In Women And MenNational Cancer Institute1993–1994
  • Preventive Oncology Academic AwardNational Cancer Institute1990–1994
  • Environmental Risk Factors And Breast Cancer In MarylandNational Cancer Institute1993
  • Serologic Precursors Of CancerNational Cancer Institute1991

Professional Memberships